This compound is a derivative of raloxifene, modified with a tert-butyldimethylsilyl (TBDMS) protecting group on the 4' phenol and retaining a hydroxy group at the 6-position. It is primarily used as a reference standard or impurity in active pharmaceutical ingredient (API) manufacturing for raloxifene-related products.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 174264-46-1
6-tert-Butyldimethylsilyl-4'-hydroxy Raloxifene
active pharmaceutical ingredient impurity
RALOXIFENE HYDROCHLORIDE
Active pharmaceutical ingredient
Raloxifene 6-Glucuronide
active pharmaceutical ingredient impurity
Methyl Raloxifene 4'-(2,3,4-Tri-O-acetyl-|A-D-glycopyranuronate)
pharmaceutical impurity reference standard
Riluzole
active pharmaceutical ingredient
Amiloride hydrochloride dihydrate
active pharmaceutical ingredient
Raloxifene Bismethyl Ether
Pharmaceutical impurity reference standard
4-Hydroxy Raloxifene
active pharmaceutical ingredient
[2-[4-[tert-butyl(dimethyl)silyl]oxyphenyl]-6-hydroxy-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone
YYSIXGNGLSNJGQ-UHFFFAOYSA-N
CC(C)(C)[Si](C)(C)OC1=CC=C(C=C1)C2=C(C3=C(S2)C=C(C=C3)O)C(=O)C4=CC=C(C=C4)OCCN5CCCCC5
—